ArticleCost effectiveness and resource allocation : C/E2025

Pioneering SMA therapies for all types: survival gains, cost dynamics, and performance-based agreements.

Ahmed Al-Jedai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.